A case of effective disease control of advanced gastric cancer following ramucirumab plus FOLFIRI in second line treatment in clinical practice

Ramucirumab is a human anti-vascular endothelial growth factor receptor 2(VEGFR-2)monoclonal antibodythat acts on vascular endothelial cells to inhibit angiogenesis. Ramucirumab in monotherapy or in combination with paclitaxel or FOLFIRI has proven to prolong overall survival in patients with pretre...

Descripción completa

Detalles Bibliográficos

Autores principales:	T. A. Titova, N. S. Besova, E. A. Artamonova
Formato:	Artigo
Lenguaje:	Russo
Publicado:	Remedium Group LLC 2020-12-01
Colección:	Медицинский совет
Materias:	gastric cancer ramucirumab second line treatment folfiri edema on vocal folds
Acceso en línea:	https://www.med-sovet.pro/jour/article/view/5957
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!